Loading data for PFSA — first visit, this takes a few seconds.
Profusa Inc. (PFSA)
NasdaqCM: PFSA
· Echtzeitkurs · USD
13.01
-14.47 (-52.66%)
Zum Schluss: Aug 19, 2026, 4:37 PM
Profusa Inc. (PFSA) Stock Price, Analysis & Data
-52.66% (1D)
Keine Daten verfügbar
| Geld | n/a |
| Marktkapitalisierung | 3.3 Mio |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | -36.56 Mio |
| Beta | 0.49 |
| EPS (ttm) | -1536.26 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | -0.04 |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | 1,207,802 |
| Ø Vol. (20D) | 1,001,556 |
| Eröffnung | 15.93 |
| Vortagesschluss | 27.48 |
| Tagesspanne | 11.71 - 17.58 |
| 52-Wk Range | 3.22 - 5190.00 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über PFSA
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in ...
Branche Medical Devices
Sektor Healthcare
IPO Datum Jul 11, 2025
Mitarbeiter n/a
Börse NasdaqCM
Tickersymbol PFSA
Website https://profusa.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Profusa 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -35.82 Mio, ein Anstieg von 288.11 %.
Finanzberichte
